Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
|
Same case as mdr id: 2134265-2016-11885.(b)(6) study.It was reported that myocardial infarction and in-stent restenosis occurred.In (b)(6) 2012, the patient presented with myocardial infarction (mi) and unstable angina and subsequently, cardiac catheterization was recommended.Two days after, index procedure was performed.Target lesion #1 was a de novo bifurcated lesion located in the mid left anterior descending (lad) artery with 99% stenosis and was 16mm long with a reference vessel diameter of 3.0mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00mmx24mm promus element¿ plus drug-eluting stent, with 0 % residual stenosis.Target lesion #2 was a de novo lesion located in the proximal left circumflex (lcx) artery with 99% stenosis and was 14mm long with a reference vessel diameter of 3.0mm.Target lesion #2 was treated with pre-dilatation and placement of a 3.00x20mm promus element¿ plus drug-eluting stent, with 0% residual stenosis.Three days after, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient presented to emergency department with the complaints of sub sternal chest pressure, nausea, vomiting, shortness of breath and diaphoresis.On the same day, 100% in-stent restenosis (isr) of study stent located in proximal lcx was attempted with aspiration thrombectomy, however a non-bsc catheter was difficult to pass into the old stent area.Then the lesion was treated with placement of 3.5x16mm promus premier drug-eluting stent.Following post dilatation, the residual stenosis was 0% and there was timi flow 3.Additionally, the100% isr of study stent located in mid lad was attempted with aspiration thrombectomy, however the non-bsc catheter was difficult to pass into the old stent area.Then the lesion was treated with placement of 3.5x16mm promus premier drug-eluting stent with 0% residual stenosis and timi flow 2.Later, intra aortic balloon pump (iabp) was inserted and pumping was performed which resulted timi flow 3.Three days after, the event was considered as resolved and the patient was discharged on the same day.
|